NCT00778024View on ClinicalTrials.gov

Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

October 31, 2003

Study Completion Date

December 31, 2003

Conditions
Healthy
Interventions
DRUG

fluoxetine HCL 40 mg capsules

Trial Locations (1)

63301

Gateway medical research, Saint Charles

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00778024 - Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter